Natalizumab discontinuation and disease restart in pregnancy: a case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natalizumab discontinuation and disease restart in pregnancy: a case series

Published:2015-01-18 Issue:5 Volume:131 Page:336-340
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

De Giglio L.¹,Gasperini C.²,Tortorella C.³,Trojano M.³,Pozzilli C.⁴

Affiliation:

1. Department of Neurology and Psychiatry; “Sapienza” Unversity of Rome; Rome Italy

2. Department of Neuroscience; “S. Camillo Forlanini” Hopsital; Rome Italy

3. Department of Department of Basic Medical Sciences; Neurosciences and Sense Organs; University of Bari; Bari Italy

4. Department of Neurology and Psychiatry; “Sapienza” University of Rome; Rome Italy

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12364/fullpdf

Reference13 articles.

1. A randomized, placebo controlled trial of natalizumab for relapsing multiple sclerosis;Polman;N Engl J Med,2006

2. Post-withdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients;Vellinga;Neurology,2008

3. Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis;O'Connor;Neurology,2011

4. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy;Miravalle;Arch Neurol,2011

5. Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning;Martinelli;Mult Scler,2013

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple sclerosis and pregnancy;The Brain of the Critically Ill Pregnant Woman;2024

2. Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients;Multiple Sclerosis and Related Disorders;2022-12

3. Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30);Multiple Sclerosis and Related Disorders;2022-10

4. Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debate;Wiener Medizinische Wochenschrift;2022-02-10

5. Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy;Degenerative Neurological and Neuromuscular Disease;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3